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Summary
Genetic hemochromatosis (GH) is believed to be a dis-
ease restricted to those of European ancestry. In north-
western Europe, 180% of GH patients are homozygous
for one mutation, the substitution of tyrosine for cysteine
at position 282 (C282Y) in the unprocessed protein. In
a proportion of GH patients, two mutations are present,
C282Y and H63D. The clinical significance of this sec-
ond mutation is such that it appears to predispose
1%–2% of compound heterozygotes to expression of
the disease. The distribution of the two mutations differ,
C282Y being limited to those of northwestern European
ancestry and H63D being found at allele frequencies
15%, in Europe, in countries bordering the Mediterra-
nean, in theMiddle East, and in the Indian subcontinent.
The C282Ymutation occurs on a haplotype that extends
6 Mb, suggesting that this mutation has arisen during
the past 2,000 years. The H63D mutation is older and
does not occur on such a large extended haplotype, the
haplotype in this case extending 700 kb. Here we re-
port the finding of the H63D and C282Y mutations on
new haplotypes. In Sri Lanka we have found H63D on
three new haplotypes and have found C282Y on one
new haplotype, demonstrating that these mutations have
arisen independently on this island. These results suggest
that the HFE gene has been the subject of selection pres-
sure. These selection pressures could be due to infectious
diseases, environmental conditions, or other genetic dis-
orders such as anemia.
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Introduction
Genetic hemochromatosis (GH [MIM 235200]) is an
autosomal recessive disease of iron overload (Bothwell
et al. 1995). GH is easily treated by phlebotomy, leading
to normal life expectancy if the disease is recognized
before the onset of severe tissue damage (Niederau et al.
1996).
The identification of the 845 GrA (C282Y) mutation
in the HFE gene (GenBank U60319) in 64%–100% of
patients with GH (Feder et al. 1996; Beutler et al. 1996;
Jouanolle et al. 1996; Jazwinska et al. 1996; Borot et
al. 1997; Worwood et al. 1997; Porto et al. 1998) has
led to population-screening studies (Merryweather-
Clarke et al. 1997; Roth et al. 1997; Cullen et al. 1998).
Much of this work has also included the analysis of a
second mutation, 187 CrG (H63D), which appears to
have a low penetrance (Feder et al. 1996).
Functional data suggest that the HFE protein with the
C282Y mutation is unable to associate efficiently with
b2-microglobulin and hence fails to reach the cell surface
(Feder et al. 1997). The proposed role for HFE is the
regulation of the interaction of the transferrin receptor
with transferrin (Feder et al. 1998; Parkkila et al. 1997;
Lebro´n et al. 1998). Clearly, if the mutant protein is
unable to reach the cell surface, then this regulatory fea-
ture is missing. The C282Y mutation is closely associ-
ated with GH in white populations. The role of a second
mutation in the HFE gene, 187 CrG (H63D), is less
clear. Current data suggest that this mutant protein can
associate with b2-microglobulin and does reach the cell
surface and that the defect lies in a failure to modify the
affinity of the transferrin receptor for transferrin (Feder
et al. 1998; Lebro´n et al. 1998). This does not explain
the low degree of penetrance associated with this
mutation.
Both these mutations alter restriction-enzyme sites,
providing easy methods for population screening. Allele
frequencies for these two mutations have been published
by a number of groups studying nonwhite populations,
including Australian Aboriginals, Taiwanese Aborigi-
nals, Indonesians, Chinese, and Pacific Islanders (Chang
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Table 1
Conditions for PCR Amplification of DNA Containing Diallelic Polymorphic Restriction-Enzyme Sites, the Relevant Restriction
Enzyme, and the Product Sizes after Digestion for the Two Different Alleles
Polymorphism Primer Sequences
Annealing
Temperature
(C)
Extension
Time
(min)
Restriction
Enzyme
Product
Size(s)
(bp)
984 Forward, 5′ -GATCCTTTAACCGAGGAGAT 54C 1 BbvI G: 511, 56
Reverse, 5′-CACTGGCCCACCTAAAT C: 567
S65C Forward, 5′-TCTGTCTAATCATGAGTATT 52 1 HinfI S: 369, 70, 68, 8
Reverse, 5′-CTTGCTGTGGTTGTGATTTTCC C: 435, 70, 8
IVS 2 (5) Forward, 5′-ACATGGTTAAGGCCTGTTG 56 1 RsaI T: 556, 245, 19
Reverse, 5′-TGCCACTAGAGTATAGGGGC C: 396, 245, 160, 19
IVS 4 (44) Forward, 5′-TGTCTCTCCTGTAGCTTGTT 55 1 Sau96I T: 523, 194, 108
Reverse, 5′-TTCTGTCTCCCAGGGAGCT C: 305, 218, 194, 108
IVS5 (47) Forward, 5′-CCTGAACATCTGTGGTGTAG 56 1.5 BanI G: 680, 440, 307, 115
Reverse, 5′-TGGGACTACAGGCGTCTGC A: 967, 404, 151
Poly A 5 Forward, 5′-CTTGGGGATTCTTCCATCT 55 1.5 RsaI C: 1,350, 367, 301, 123
Reverse, 5′-CCGTAAGACAAAATGTAAAG T: 1,350, 424, 367
Table 2
HFE Mutations and Polymorphisms, with Nucleotide Changes and
Their Positions within HFE
POLYMORPHISM
NUCLEOTIDE
CHANGE
POSITION
Relative to
Initiating ATG In HFE
984 GrC 1206 5′ Non-coding
H63D CrG 3513 Exon 2
S65C ArT 3519 Exon 2
IVS 2 (5) TrC 3670 Intron 2
C282Y GrA 5473 Exon 4
IVS 4 (44) TrC 5635 Intron 4
IVS 5 (47) GrA 6699 Intron 5
Poly A 5 CrT 9378 Exon 7
et al. 1997; Merryweather-Clarke et al. 1997; Cullen et
al. 1998).
The population of Burma (Myannmar) is extremely
heterogeneous, because of multiple migrations by dif-
ferent ethnic groups who have entered Burma from Tibet
in the north and from east of the Mekong river. Burmans
form the main ethnic group (65%) (Enriquez 1978). His-
torically, Khmers have entered Burma, Laos, and Kam-
puchea from the northeast. The island of Sri Lanka too
has been subject to many population migrations. The
original inhabitants (the Veddahs) represent a minor part
of the present population. The largest ethnic groups now
on the island originated from nearby India. The Sin-
halese are thought to have originated from northeastern
India at ∼500 B.C. and represent the largest sector of the
current population. The Tamils were from southern In-
dia and arrived in Sri Lanka mainly by a succession of
invasions between the 3d and 12th centuries A.D. We
report here the results of screening for these two mu-
tations in 84 unrelated Burmese and 54 unrelated Khmer
from Laos and Cambodia who are living in France as
first-generation immigrants, as well as the results of fur-
ther data from Sri Lanka that suggest that HFE muta-
tions have arisen in more than one population.
Subjects and Methods
Subjects
DNA was prepared from 84 unrelated Burmese from
a thalassemia study and from 54 unrelated Khmer from
Laos and Cambodia who were living in France as first-
generation immigrants. The samples from Sri Lanka
formed part of a large study investigating the interaction
of b-thalassemia with hemoglobin E in the context of
iron overload. French DNA samples were used as con-
trols and represent a European population. Appropriate
informed consent was given when the blood samples
were collected for DNA analysis.
Methods
DNA was extracted from blood samples by standard
methods. PCR amplifications of the HFE gene contain-
ing the H63D and C282Y mutations and analysis of the
PCR products were performed as described elsewhere
(Merryweather-Clarke et al. 1997).
Three diallelic polymorphisms—IVS 2 (5), IVS 4
(44), and IVS 5 (47)—have been reported for the
HFE gene (Beutler and West 1997). We have modified
the PCR conditions to include internal control restric-
tion-enzyme sites in the amplified product. Primer se-
quences and PCR conditions are given in table 1. The
rare exonic polymorphism S65C has been described and
shows no association with disease (Henz et al. 1997);
PCR conditions for determining this are given in table
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Table 3
Allele Frequencies for C282Y and H63D Mutations in Southeast
Asian Chromosomes
NO. OF
ETHNIC GROUP Individuals 845 A 187 G
Burma 52 0 2
Karen 4 0 1
Burman/Karen 12 0 1
Burman/Chinese 11 0 1
Burman/Indian 4 0 0
Khmer 54 0 3
Total 137 (274 alleles) 0 (0 alleles) 8 (2.9% of alleles)
1. Two further polymorphisms have been identified by
sequencing and are described in the present study:984
(GrC) and poly A 5 (CrT). PCR conditions and re-
striction-enzyme details are given in table 1. The relative
positions of the polymorphisms used in the present study
are given in table 2.
All the polymorphic sites were determined by PCR
amplification followed by restriction-enzyme digestion
of the products. All PCR reactions were performed as
25-ml reactions in microtiter plates by a Hybaid thermal
cycler, followed by digestion with the appropriate en-
zyme at 37C for 4 h. Amplifications were performed
by use of 0.625 units of AmpliTaq DNA polymerase
(Perkin-Elmer) in a buffer containing 1.5 mM MgCl2,
10 mM Tris-HCl pH 8.3 at 25C, 50 mM KCl, 100 mM
dNTPs, and 50 ng of each primer, except for the IVS 5
(47) reaction, which was performed by use of the
Boehringer Expand High Fidelity PCR kit (Roche Di-
agnostics). All products were resolved on 2% agarose
gels, except those for the 984 GrC polymorphism,
which were resolved by use of 3% agarose gels. Restric-
tion enzymes were used in accordance with the manu-
facturer’s instructions.
The microsatellite markers D6S105, D6S1260, and
D6S1558 were amplified as described elsewhere (Weber
et al. 1991; Raha-Chowdhury et al. 1995; Dib et al.
1996), except that the forward primer was labeled with
T4 polynucleotide kinase and [33P]g-ATP prior to PCR
amplification. Products were resolved on 6% denaturing
polyacrylamide gels, and the product sizes were deduced
by use of both sequencing ladders and control samples
of known size. The b-globin–gene haplotype analysis
was performed as described elsewhere (Varawalla et al.
1992; Flint et al. 1993).
Results
The 845 GrA transition was absent from all ethnic
groups from Southeast Asia that were studied (table 3).
This result is consistent with the hypothesis that this
mutation is of northern European origin. The 187 CrG
transversion is present and gives an overall allele fre-
quency of 2.9%, with a nearly equal distribution in all
ethnic groups (table 3). This result is consistent with the
observations of others (Merryweather-Clarke et al.
1997; Cullen et al. 1998), who have found a similar
frequency among Hong Kong Chinese and Indonesians
and in both northern and southern Chinese. This allele
frequency is much lower than either that in European
populations (average 13.6%) or those in ethnic groups
from northern and eastern Africa (8.9% and 9.4%, re-
spectively) (Merryweather-Clarke et al. 1997; Roth et
al. 1997). High allele frequencies have been observed
both in Saudi Arabia and the Indian subcontinent (8.5%
and 8.4%, respectively) (Merryweather-Clarke et al.
1997). The highest allele frequencies for the 187 CrG
mutation have been reported for regions bordering the
Mediterranean (Merryweather-Clarke et al. 1997; Roth
et al. 1997).
These results for H63D could be explained by gene
flow between peoples around the Mediterranean,
spreading into the Indian subcontinent. The HLA data
reported by Cullen et al. (1998) suggest (a) that it is
unlikely that this mutation was introduced into South-
east Asia with European chromosomes and (b) that it
predates the C282Y mutation. It could be inferred from
this that the 187 CrG mutation may well have occurred
at least twice—once in the Mediterranean and once in
Asia.
To demonstrate this, we have haplotyped individu-
als who carry the H63D mutation, for three diallelic
polymorphisms in the HFE gene (Beutler and West
1997). Of the five individuals from Burma who were
H63D heterozygotes, all had a combination of alleles
compatible with haplotype 6—(IVS 2 (4) C, IVS 4
(44) T, IVS 5 (47) A [hereafter, “CTA”]) (Beutler
and West 1997)—that is tightly associated with Euro-
pean chromosomes carrying the H63D mutation. Only
one individual could have carried the H63D chromo-
some bearing haplotype 1 (TTG), a combination that
we have found in Sri Lanka. In a study using both Eur-
opean and Asian chromosomes, H63D was found only
in association with haplotype 6 (Beutler and West 1997).
Since H63D was present at such a low frequency in
the Burmese and Khmer samples, we extended the study
by examining a selection of Sri Lankan chromosomes in
which the H63D allele frequency is ∼10% (Merry-
weather-Clarke et al. 1997). Of the 14 unrelated Sri
Lankan chromosomes that carried the H63D mutation,
6 had a combination of alleles compatible with haplo-
type 6 (CTA). Since there were two H63D homozygotes
in the Sri Lankan samples, it was possible to conclude
that H63D occurred on either haplotypes 1 (TTG), 2
(TTA), and 5 (CTG) or haplotypes 1 (TTG), 5 (CTG),
and 6 (CTA) (fig. 1). The Sri Lankan samples also formed
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Figure 1 Sri Lankan pedigree showing homozygosity for H63D,
in two generations. Unfortunately, the father was unavailable for study,
since this family lives close to the Jaffna Peninsula. The mother has
two possible haplotype combinations defined as A or B. The child is
homozygous for the markers tested except IVS4 (44); thus she carries
H63D chromosomes bearing haplotypes 1 and 5.
Figure 2 Sri Lankan pedigree in which mutations C282Y and
H63D are segregating with haplotypes 5 (CTG) and 2 (TTA), respec-
tively. The father is a compound heterozygote for the two mutations,
and the mother is homozygous at the five loci tested; thus the daughter
clearly has inherited the H63D mutation from her father, on a chro-
mosome bearing haplotype 2.
part of a larger family study, so it was possible to assign
haplotypes in a further set of chromosomes. One of 14
Sri Lankan chromosomes was haplotype 2 (TTA) (fig.
2), 2 were haplotype 5 (CTG), and 1 was haplotype 1
(TTG) (fig. 1). Of the chromosomes that could not
be assigned unambiguous haplotypes, haplotypes 1, 2,
and 5 were possible on 5, 4, and 5 chromosomes,
respectively.
While sequencing the HFE gene from different chro-
mosomes, we found two further diallelic polymorphisms
that lend themselves to restriction-enzyme analysis. The
first polymorphism (984 GrC) lies 984 nucleotides
upstream of the start of transcription, and the second
polymorphism (poly A 5 CrT) lies 5 nucleotides be-
yond the poly A adenylation signal. These two poly-
morphisms can therefore be used to extend the haplo-
types described by Beutler and West (1997). We have
screened a selection of chromosomes for these poly-
morphisms; the results are shown in table 4, together
with the results of the screening of chromosomes for
H63D, S65C, C282Y and for the three diallelic poly-
morphisms used in the haplotype analysis. As has been
found in other studies (e.g., Feder et al. 1996), the two
mutations C282Y and H63D were not found on the
same chromosome.
One of the Sri Lankan samples was from a C282Y/
H63D compound heterozygote (fig. 2). Thus far, the
C282Y mutation has only been found associated with
haplotype 1 (TTG), when the haplotyping method of
Beutler and West (1997) has been used. It has been as-
sumed that the C282Y mutation will only be found on
a chromosome bearing haplotype 1 (TTG), since the
C282Y mutation has been thought to have occurred only
once. On the basis of our results, it can be inferred that
H63D is associated with haplotype 2 (TTA) and that
C282Y is associated with haplotype 5 (CTG), which
Beutler and West found on 1.9% of their Asian chro-
mosomes (Beutler and West 1997). This individual is
from an orthodox Sinhalese background, so it is unlikely
that there will be Tamil or Muslim chromosomes seg-
regating in this pedigree.
Haplotypes 1 and 5 differ at one position, where a C
(IVS 2 (5) is substituted for a T. We therefore extended
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the haplotype analysis in this family, using microsatellite
markers that have been used to define the extended Eur-
opean hemochromatosis haplotype (fig. 2). The peak of
linkage disequilibrium lies on the proximal side of the
HFE gene, extending 4.5 Mb (Feder et al. 1996). The
microsatellite markers D6S1260 and D6S1558 lie prox-
imal to the HFE gene and were uninformative, since
all three family members were heterozygous for the same
alleles. The family was informative for D6S105, a
marker that lies 1.7 Mb proximal to the HFE gene (fig.
2). In this family, allele 5 of D6S105 segregates with the
chromosome bearing the C282Y mutation. In popula-
tions of European descent, allele 8 is most commonly
associated with GH chromosomes, having a gene fre-
quency of .62 in patients and .12 in controls (Jazwinska
et al. 1993). In populations of European descent, allele
5 of D6S105 has a gene frequency of .06–.07 in GH
patients and .15–.18 in controls (Jazwinska et al. 1993;
Worwood et al. 1994).
The b-globin gene was used as a second independent
marker in this family, to confirm family relationships
(fig. 2). The father and mother have b-globin haplotypes
V and VII and b-globin haplotypes VII and X, respec-
tively. Their child is homozygous for haplotype VII, car-
rying the b-thalassemia mutation, IVS1-5 (GrC), and is
affected with b-thalassemia.
Discussion
These data suggest that, in Asia, the H63D mutation
in the HFE gene occurs on three haplotypes with which
it is not associated in Europe and support the idea that
the H63D mutation may have arisen more than once.
In Europe, the H63D mutation is associated with hap-
lotype 6 (CTA). In Sri Lanka, family studies have dem-
onstrated that the H63D mutation has occurred on the
following three new haplotype backgrounds: haplotype
1 (TTG), haplotype 2 (TTA), and haplotype 5 (CTG).
Two of the haplotypes differ from haplotype 6 (CTA),
for the IVS 2 (5) polymorphism, which is 157 bp from
the H63D mutation. Two of the three haplotypes differ
from haplotype 6, for the third polymorphism, which is
3.2 kb from the H63D mutation. All these polymor-
phisms lie within the HFE gene. A major problem in
identifying the HFE gene was the lack of recombination
in the gene region—in particular, recombination between
HFE and HLA-A—so it is unlikely that recombination
is responsible for our observations. We also observed a
chromosome bearing the C282Y mutation together with
haplotype 5 (CTG), which differs, at one position, from
haplotype 1 (TTG). This CrT nucleotide change is only
1.8 kb from the C282Y mutation. Together, these data
suggest that, in Sri Lanka, both the C282Y mutation
and the H63D mutation have arisen independently from
the mutations occurring in Europe.
This is the first report of the C282Y mutation occur-
ring on a chromosome that clearly does not bear the
classic haplotype associated with hemochromatosis pa-
tients from Europe. Our results suggest that there is or
has been selection pressure favoring this mutation, mak-
ing genetic drift an unlikely explanation. The selection
pressures could be single or multiple. Wild-type HFE is
expressed at the cell surface. One could speculate that
this protein is the receptor for some infectious agent; a
similar suggestion has been proposed with regard to the
cystic fibrosis transmembrane regulator (CFTR) protein
(Pier et al. 1998). It has been demonstrated that Sal-
monella typhi, the agent for typhoid fever, uses CFTR
to enter wild-type intestinal epithelial cells, entering cells
heterozygous for the common cystic fibrosis DF508 mu-
tation inefficiently and failing to enter cells homozygous
for the DF508 mutation (Pier et al. 1998). A similar
mechanism involving an infectious agent could explain
the selection of the C282Y-mutant form of HFE, since
this form of the protein does not reach the cell surface
because it cannot associate correctly with b2-microglob-
ulin. The region of the protein that might be involved
could be exon 3, which encodes the a2 domain where
the H63D mutation is found. Since this mutation is re-
ported to be of low penetrance and causes disease in
only a proportion of patients who are H63D/C282Y
compound heterozygotes and in even fewer H63D ho-
mozygotes, there must be little heterozygote or homo-
zygote disadvantage. Until now, it has been assumed that
the selective advantage conferred by HFE mutations was
the prevention of iron deficiency; this would include pro-
tection against anemia due to hookworm infestation,
malaria, multiple pregnancies, a diet lacking in iron, or
any combination of these factors. If this were solely the
case, then one might expect that one or more of the HFE
mutations would have reached fixation in countries
where there are high levels of anemia; however, this
has yet to be observed. On the basis of our current un-
derstanding, it can be inferred that, for either mutation,
there is little reproductive disadvantage to C282Y ho-
mozygotes and even less to heterozygotes, a situation
that would be expected to favor selection for these mu-
tations if protection against anemia were so
advantageous.
GH has been recognized only among populations of
northern European origin. Thalassemia, a serious disease
both in peoples of Mediterranean and in peoples of
Asian descent, is a major contributory factor in iron
overload. Screening for the 187 G allele in thalassemic
patients may be relevant, since this mutation may be
another contributory factor in iron overload.
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